If a drug increases GLP-1 secretion but impairs ghrelin production, which consequence follows for a patient with insulin resistance?

💡 Explanation

Elevated GLP-1 enhances insulin secretion and reduces glucagon, whereas reduced ghrelin diminishes appetite stimulation. Because of this combined effect, the patient experiences enhanced satiety and subsequent weight loss; therefore, option C is correct rather than the others which involve opposing metabolic effects.

• Which membrane polarization results when potassium channels close?
• A patient with hypertension has increased arterial stiffness and reduced baroreceptor sensitivity. If the RAAS system is chronically overactive, which outcome is most likely?
• Which consequence results when the temperature compensation mechanism fails within thyroid feedback loops?
• Which outcome results due to a compromised muco-ciliary clearance system?
• Why does blood pressure sometimes remain elevated in hypertension patients even after administration of ACE inhibitors?
• What distinguishes presbycusis-related hearing loss from noise-induced hearing loss in a sound engineer who regularly monitors high-decibel audio?